CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

February 23rd, 2012

FDA Grants MI Indication for Drug-Eluting Stents

Boston Scientific announced on Wednesday that the FDA had approved the use of its Ion and Taxus Liberte paclitaxel-eluting stents for the treatment of patients with MI. These are the first drug-eluting stents to receive a specific indication for MI.

The new indication is based on data from the Taxus clinical program and the HORIZONS-AMI trial. Acute MI accounts for about 10% of  coronary interventions, according to the company.

Categories: Uncategorized
Tags: , , ,


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.